During the Targeted Radiopharmaceuticals Summit, James Nagarajah gave a presentation. In his presentation he spoke about the challenges that can be faced during the development of a new radio pharmaceutical, and how these can be overcome by collaborating with suppliers, industry partners and medical institutes.
On the 3rd of February more than 2,6 million people in the Netherlands watch the NOS news at 8 p.m., which features an item on the growing number of cancer patients in the Netherlands.